![Karen Agersborg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 82 763 $ al 30/09/2026
Karen Agersborg has held positions as an Independent Non-Executive Director at Clinuvel Pharmaceuticals Ltd. since 2018 and is currently a Member at the American Osteopathic Association.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 13.833 ( 0,03 % ) | 82 763 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Director/Miembro de la Junta | 29/01/2018 |
American Osteopathic Association
 American Osteopathic Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for osteopathic medical doctors and students | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
American Osteopathic Association
American Osteopathic Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for osteopathic medical doctors and students | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
